New trials are looking at what could be the next therapy or one that layers on top of present therapies to treat lung diseases, said Lisa Lancaster, MD, assistant professor of medicine at Vanderbilt Health.
New trials are looking at what could be the next therapy or one that layers on top of present therapies to treat lung diseases, said Lisa Lancaster, MD, assistant professor of medicine at Vanderbilt Health.
Transcript
Are there any particular trials within the pulmonary or allergy space that you are interested in?
There are multiple different compounds that are being studied in clinical trials that with hope could be the next best therapy that is given independently or perhaps even layered on the therapies that we have presently. We’re very optimistic about what we’ve learned in the past but realize that we have a lot more to learn about the disease. In other words, how do we get to this end pattern of fibrosis, this usual interstitial pneumonitis injury pattern. And there are likely multiple different roads and pathways to get there.
We’re building on our knowledge of genetics in this area, and that’s truly going to be foundational and may end up guiding our therapeutic choices down the road. Perhaps patients with a certain genetic mutation may do better with one therapy than another.
Do you think wearable technology offers any value in detection or observation for sleep apnea and other respiratory conditions?
Studies have been completed and are still ongoing looking at home spirometry for patients with interstitial lung disease. So, that may be something we utilize in the future to monitor patients in the home setting, between their clinic visits.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Mental Health Diagnoses, Care Challenges Rise Among US Youth, Report Finds
April 26th 2024While behavioral health care utilization has been rising, the treatment landscape has been worsening. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial behavioral health diagnosis.
Read More